Nguyen
10-21-2022, 09:14 AM
Liquid biopsy–based biomarkers for the characterization of hormone receptor-positive (HR+) HER2-Low metastatic breast cancer (mBC)
https://www.annalsofoncology.org/article/S0923-7534(22)02151-2/fulltext
https://www.annalsofoncology.org/article/S0923-7534(22)02151-2/fulltext